EMA Seeks Input on a “Tailored Clinical Approach” in Biosimilar Development
By EsqSocial Corporation 08/04/25
On April 1, 2025, the European Medicines Agency opened the consultation period for its draft reflection paper on a tailored clinical approach in biosimilar development....
By: Goodwin